2Antoine Adenis,Jean-Marc Pion,Pierre Fumoleau,Pierre Pouillart,Michel Marty,Bruno Giroux,Jacques Bonneterre. Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer[J] 1995,Cancer Chemotherapy and Pharmacology(6):527～528
5Depierre A,Jacoulet P,Gamier G.Efficacy of Navelbine and vinca alkaloids in the treatment of non-small-cell lung cancer (NSCLC)[J]. Oncoloie PF. Navelbine:Update and New Trends [M].Montrouge: John Libbty Eurotext Ltd, 1991.133
6Chevalier TL,Brisgand D,Dourllard JY,et al.Randomized study of vinorebline and cisplatin versus vindesine and cisplatin versus vinorebline alone in advanced non-small-cell lung cancer:results of a European multicenter trial including 612 patients [J].Clin Oncol, 1994,12(2): 360-367
7Chevalier TL, Berthan P,Suffie P.NVB and high-dose PDD in advanced non-small-cell lung cancer(NSCLC):results of phase I - II study and design of multieenter randomized phase III study [J].J Cancer Res Clin Oncol,1990,166(II): 1 052-1 056
8Krikorian A.Pharmacokinetics of navelbine.Oncoloie PF.Navelbine: Update and new trends [M].Montrouge:John Libbey Eurotext Ltd, 1991.43-52
9孙燕．内科肿瘤学[M]．第3版．北京：人民卫生出版社，2003．994-997
10Le Chevaliver T,Brisgand D,Pujol JL,et al.Randomized study of navelbine registered and cisplatin versus vindesine and cisplatin versus navelbine registered alone in 612 patients with advanced nonsmall cell lung cancer(NSCLC)[J].Bull cancer,1996,83: 385-394
